Quarterly report pursuant to Section 13 or 15(d)

Common Stock Equivalents (Details)

v3.19.3.a.u2
Common Stock Equivalents (Details) - shares
6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 7,745,464 7,776,357
Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 2,242,665 2,087,064
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 541,999 728,493
Convertible Notes [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents, total 4,960,800 4,960,800